Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction

The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction

1993 • 1,861 citations

A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial Infarction

1993 • 1,311 citations

Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction

1993 • 820 citations

Effect of Glycoprotein IIb/IIIa Receptor Blockade on Recovery of Coronary Flow and Left Ventricular Function After the Placement of Coronary-Artery Stents in Acute Myocardial Infarction

1998 • 545 citations

Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival

1986 • 510 citations

Randomized Comparison of Coronary Stenting With Balloon Angioplasty in Selected Patients With Acute Myocardial Infarction

1998 • 357 citations

A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction

1996 • 339 citations

Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI)

1997 • 289 citations

Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure.

1994 • 284 citations

Secondary prevention in coronary heart disease: baseline survey of provision in general practice

1998 • 238 citations

Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands

1989 • 225 citations

Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.

1993 • 204 citations

The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol

1996 • 189 citations

Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review

1997 • 180 citations

Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey

1999 • 177 citations

Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.

1994 • 172 citations

Thrombolytic Therapy for Acute Myocardial Infarction

1992 • 160 citations

Randomized Comparison of Primary Coronary Angioplasty With Thrombolytic Therapy in Low Risk Patients With Acute Myocardial Infarction

1997 • 145 citations

Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.

1990 • 122 citations

Use of Aspirin, β-Blockers, and Lipid-Lowering Medications Before Recurrent Acute Myocardial Infarction

1999 • 111 citations

A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction

1995 • 93 citations

Should Thrombolysis or Primary Angioplasty Be the Treatment of Choice for Acute Myocardial Infarction?

1996 • 73 citations

Fortnightly review: Secondary prevention in acute myocardial infarction

1998 • 53 citations

THERAPEUTIC TRIALS IN CORONARY THROMBOSIS SHOULD MEASURE LEFT VENTRICULAR FUNCTION AS PRIMARY END-POINT OF TREATMENT

1988 • 47 citations

Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction

1995 • 45 citations

Cited By (0)

Loading...